McKesson Aktie News

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on July 1, 2024, to stockholders of record on June 3, 2024. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patien...

Healthcare stocks, especially industry leaders that offer a wide range of products and services, can be an investor's best friend due to the growing need for increased development of healthcare products and services. These stocks tend to provide investors with a substantial return on their investment.

IRVING, Texas--(BUSINESS WIRE)--McKesson launches Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations webs...

Pharmacy chain Rite Aid has reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson Corp , clearing a path for Rite Aid to complete its bankruptcy case by late April, a company lawyer said Tuesday.

IRVING, Texas--(BUSINESS WIRE)--Register for McKesson ideaShare, a premier community pharmacy annual education and networking event, in New Orleans from June 23-26, 2024.

McKesson reported 15% topline growth and 12.2% adjusted EPS growth in their recent earnings report. The company's GLP-1 medications have shown impressive growth, contributing 60% to year-over-year growth. McKesson's strong distribution network and the increasing demand for GLP-1 medications position them for continued growth opportunities.

IRVING, Texas--(BUSINESS WIRE)--McKesson received approval from CMS to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry for the 8th year.